Accuracy of Non Invasive Hemoglobin Measure by SpHb Device in Post Operative Anemia Diagnosis (SpHb_gyneco)

July 4, 2024 updated by: University Hospital, Angers

Accuracy of Non Invasive Hemoglobin Measure by SpHb Device in Post Operative Anemia Diagnosis: a Validation Study in Gynecological Surgery Department of Angers 's University Hospital

Non invasive Hemoglobin monitoring by SpHb device had been developed to assess Hemoglobin level during hemorrhagic surgery. It's accuracy to detect post operative anemia on a single post operative measure has been recently demonstrated on a cohort of post operative orthopedic patient and it's routine use has been generalized to other surgical department. This study aims to valid these finding on a cohort of post operative patients from gynaecological department.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

population of gynecological surgical department

Description

Inclusion Criteria:

  • being hospitalized for gynecological procedure: hysterectomy or cancer related annexectomy
  • > 18 years

Exclusion Criteria:

  • non french speaker
  • being under a legal individual protection measure
  • not being able to consent
  • being opposed to data collection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
accuracy between SpHb measure and Hemoglobin level on the post operative blood sample
Time Frame: at 2 and 8 months after establishment of PBM protocol
level of immediate post operative SpHb measure compared to blood hemoglobin measure, ROC curve
at 2 and 8 months after establishment of PBM protocol

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spearman correlation coefficient
Time Frame: at 2 and 8 months after establishment of PBM protocol
correlation between Laboratory Hb and SpHb measure
at 2 and 8 months after establishment of PBM protocol
Kappa coefficient
Time Frame: at 2 and 8 months after establishment of PBM protocol
correlation between SpHb measure and correct classification of patients anemia vs no anemia
at 2 and 8 months after establishment of PBM protocol
Intra class correlation coefficient
Time Frame: at 2 and 8 months after establishment of PBM protocol
correlation between Laboratory measurement and SpHb measurement
at 2 and 8 months after establishment of PBM protocol
Subgroup analysis of ROC curve (classes of age 18-30; 30-40; 40-50; >50)
Time Frame: at 2 and 8 months after establishment of PBM protocol
comparison of ROC curve areas in subgroups
at 2 and 8 months after establishment of PBM protocol
impact of body temperature on accuracy of SpHb
Time Frame: at 2 and 8 months after establishment of PBM protocol
comparison of ROC curve areas in subgroups of temperature (classes of temperature : <35; 35-36; >36)
at 2 and 8 months after establishment of PBM protocol
impact of perfusion index on accuracy of SpHb
Time Frame: at 2 and 8 months after establishment of PBM protocol
comparison of ROC curve areas in subgroups of perfusion index (good or low perfusion index)
at 2 and 8 months after establishment of PBM protocol
impact of leght between SpHb measurement and laboratory Hb measurement on accuracy
Time Frame: at 2 and 8 months after establishment of PBM protocol
comparison of ROC curve areas in subgroups of lenght in days between SpHb measurement and Laboratory Hb measurement
at 2 and 8 months after establishment of PBM protocol

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sigismond Lasocki, University Hospital, Angers

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 30, 2024

Primary Completion (Estimated)

January 1, 2026

Study Completion (Estimated)

January 1, 2026

Study Registration Dates

First Submitted

June 18, 2024

First Submitted That Met QC Criteria

July 4, 2024

First Posted (Actual)

July 11, 2024

Study Record Updates

Last Update Posted (Actual)

July 11, 2024

Last Update Submitted That Met QC Criteria

July 4, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anemia

Clinical Trials on non invasive hemoglobin measure

Subscribe